Hendrix Genetics named Antoon van den Berg as chief executive officer. He will succeed Jolanda van Haarlem who has decided to leave Hendrix Genetics to take the next step outside the company. Antoon van den Berg will step down from the Supervisory Board and Wout Dekker will join the Supervisory Board.
Jolanda van Haarlem has played an instrumental role in bringing the company to the next phase by bringing Paine Schwartz Partners on board as a new shareholder and formulating the strategy for 2026. She considers it the right moment to take the next step. To ensure continuity and minimal disruption to the company, the supervisory board invited Antoon van den Berg to step back in the role of CEO of Hendrix Genetics with immediate effect. Antoon has held this position from the foundation of Hendrix Genetics in 2005 until May 2021.
Wout Dekker brings many years of experience not only in the agri-food sector but also in supervisory boards of international companies. After completing his MSc in animal science at Wageningen University in 1983, Wout Dekker joined the company that we now know as Nutreco. From 2000 to 2012, he was the CEO of Nutreco involved in the divestment of Euribrid to Hendrix Genetics. Since he stepped down as CEO of Nutreco, he has been involved in several supervisory boards in the profit and non-profit sector, including Rabobank, FrieslandCampina and Princess Maxima center for child oncology. Currently, Wout is a member of the supervisory board of SHV Holdings NV, Pon Holdings NV, and Randstad NV. As a member of the supervisory board, he wants to contribute to the further development of Hendrix Genetics in a fast-changing world and help it realize its strategy.